For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile...
Read moreDetailsLondon, UK – 24th April 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on...
Read moreDetailsQuadient Named a Leader in the SPARK Matrix™: Customer Communication Management Report for 2025 QKS Group recognizes Quadient for its...
Read moreDetailsMYT Netherlands Parent B.V. (“Mytheresa”) and Richemont announce the successful completion of Mytheresa’s acquisition of YOOX NET-A-PORTER (“YNAP”) 24 April 2025...
Read moreDetailsPrimary endpoint met, no drug-related serious adverse events Positive hematoma and edema volume evolutionRecruitment stopped early due to positive exploratory...
Read moreDetailsTarkett Participation increases the price offered in its public buy-out OfferTarkett's Supervisory Board issues a favorable reasoned opinion based on...
Read moreDetailsLeiden, the Netherlands, April 24, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited)...
Read moreDetailsPRESS RELEASE Paris, April 24, 2025, 8:00 am Eramet: 2.7bn€ in economic contribution and 260,000 beneficiaries of social initiatives in the...
Read moreDetailsGROUP CEO’S REVIEW The first quarter of 2025 continued the moderate recovery in Estonia’s real estate market that began at...
Read moreDetailsNEW YORK, NEW YORK AND GOTHENBURG, SWEDEN (April 24, 2025) — Anonybit, a pioneer in decentralized biometrics has announced a new...
Read moreDetails